BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21518930)

  • 1. RUNX1 regulates corepressor interactions of PU.1.
    Hu Z; Gu X; Baraoidan K; Ibanez V; Sharma A; Kadkol S; Munker R; Ackerman S; Nucifora G; Saunthararajah Y
    Blood; 2011 Jun; 117(24):6498-508. PubMed ID: 21518930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
    Gu X; Hu Z; Ebrahem Q; Crabb JS; Mahfouz RZ; Radivoyevitch T; Crabb JW; Saunthararajah Y
    J Biol Chem; 2014 May; 289(21):14881-95. PubMed ID: 24695740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity.
    Zhao X; Jankovic V; Gural A; Huang G; Pardanani A; Menendez S; Zhang J; Dunne R; Xiao A; Erdjument-Bromage H; Allis CD; Tempst P; Nimer SD
    Genes Dev; 2008 Mar; 22(5):640-53. PubMed ID: 18316480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
    Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
    J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pin1-mediated prolyl isomerization of Runx1 affects PU.1 expression in pre-monocytes.
    Islam R; Yoon WJ; Woo KM; Baek JH; Ryoo HM
    J Cell Physiol; 2014 Apr; 229(4):443-52. PubMed ID: 24037986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations.
    Huang G; Zhao X; Wang L; Elf S; Xu H; Zhao X; Sashida G; Zhang Y; Liu Y; Lee J; Menendez S; Yang Y; Yan X; Zhang P; Tenen DG; Osato M; Hsieh JJ; Nimer SD
    Blood; 2011 Dec; 118(25):6544-52. PubMed ID: 22012064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runx1 promotes murine erythroid progenitor proliferation and inhibits differentiation by preventing Pu.1 downregulation.
    Willcockson MA; Taylor SJ; Ghosh S; Healton SE; Wheat JC; Wilson TJ; Steidl U; Skoultchi AI
    Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17841-17847. PubMed ID: 31431533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
    Cooper S; Guo H; Friedman AD
    PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-specific action of Runx1 and GATA3 controls silencing of PU.1 expression in mouse pro-T cells.
    Hosokawa H; Koizumi M; Masuhara K; Romero-Wolf M; Tanaka T; Nakayama T; Rothenberg EV
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34180951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.
    Simeoni F; Romero-Camarero I; Camera F; Amaral FMR; Sinclair OJ; Papachristou EK; Spencer GJ; Lie-A-Ling M; Lacaud G; Wiseman DH; Carroll JS; Somervaille TCP
    Cell Rep; 2021 Sep; 36(12):109725. PubMed ID: 34551306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification of (ETV6)/RUNX1-regulated genes in lymphopoiesis using histone deacetylase inhibitors in ETV6/RUNX1-positive lymphoid leukemic cells.
    Starkova J; Madzo J; Cario G; Kalina T; Ford A; Zaliova M; Hrusak O; Trka J
    Clin Cancer Res; 2007 Mar; 13(6):1726-35. PubMed ID: 17325341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ski can negatively regulates macrophage differentiation through its interaction with PU.1.
    Ueki N; Zhang L; Hayman MJ
    Oncogene; 2008 Jan; 27(3):300-7. PubMed ID: 17621263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Runx1 regulates embryonic myeloid fate choice in zebrafish through a negative feedback loop inhibiting Pu.1 expression.
    Jin H; Li L; Xu J; Zhen F; Zhu L; Liu PP; Zhang M; Zhang W; Wen Z
    Blood; 2012 May; 119(22):5239-49. PubMed ID: 22493295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
    Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G
    Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-type-specific activation and repression of PU.1 by a complex of discrete, functionally specialized cis-regulatory elements.
    Zarnegar MA; Chen J; Rothenberg EV
    Mol Cell Biol; 2010 Oct; 30(20):4922-39. PubMed ID: 20696839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone H4 HDAC activity is necessary for expression of the PU.1 gene.
    Laribee RN; Klemsz MJ
    Biochim Biophys Acta; 2005 Sep; 1730(3):226-34. PubMed ID: 16139904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase 1 activates PU.1 gene transcription through regulating TAF9 deacetylation and transcription factor IID assembly.
    Jian W; Yan B; Huang S; Qiu Y
    FASEB J; 2017 Sep; 31(9):4104-4116. PubMed ID: 28572446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RUNX1-PU.1 axis in the control of hematopoiesis.
    Imperato MR; Cauchy P; Obier N; Bonifer C
    Int J Hematol; 2015 Apr; 101(4):319-29. PubMed ID: 25749719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
    Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
    Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia.
    Chen PM; Yen CC; Wang WS; Lin YJ; Chu CJ; Chiou TJ; Liu JH; Yang MH
    Int J Oncol; 2008 Jun; 32(6):1335-41. PubMed ID: 18497996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.